<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="115918">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01813968</url>
  </required_header>
  <id_info>
    <org_study_id>2011/2613</org_study_id>
    <nct_id>NCT01813968</nct_id>
  </id_info>
  <brief_title>Ischemic Postconditioning in Cardiac Surgery</brief_title>
  <acronym>IPICS</acronym>
  <official_title>Ischemic Postconditioning in Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tartu University Hospital, Estonia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Almazov Federal Center of Heart, Blood and Endocrinology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <authority>Norway: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ischemic postconditioning by repetitive cycles of reperfusion and ischemia has been proven
      both in animal models and in humans. This study aims to investigate the effect of ischemic
      postconditioning on postoperative hemodynamic function in a standard heart surgery patient
      population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ischemic postconditioning is studied using cardiopulmonary bypass (CPB) and moderate
      hypothermia (32-34°C) in a patient population undergoing surgery of the aortic valve
      (repair/replacement ) or the ascending aorta. Postconditioning is applied by introducing
      reperfusion/ischemia via the cardioplegia line while the aorta is still cross-clamped
      thereby preventing the risk of additional neurological complications. All patients &gt; 20
      years eligible for aortic or aortic valve surgery and not affected by exclusion criteria,
      will be included.

      The study is carried out as a randomised controlled multicenter study including 5-6 heart
      surgery centers.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in cardiac index between the groups during the first postoperative day</measure>
    <time_frame>The first postoperative day: measurements at 2, 8 and 18 hrs postoperatively</time_frame>
    <safety_issue>No</safety_issue>
    <description>Cardiac index is measured by a Swan-Ganz catheter inserted preoperatively</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Ischemic postconditioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ischemic postconditioning via the cardioplegia line starting with 2 min of reperfusion followed by 2 min of &quot;ischemia&quot; x 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard operating technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ischemic postconditioning</intervention_name>
    <arm_group_label>Ischemic postconditioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients undergoing elective surgery of the ascending aorta or the aortic valve

        -

        Exclusion Criteria:

          -  Coronary artery disease requiring bypass surgery

          -  Tricuspid valve surgery

          -  Mitral valve surgery

          -  Atrial fibrillation (permanent or paroxysmal with or without concomitant ablation
             procedure)

          -  Patients on per oral or parenteral steroid therapy (inhalational steroids are
             allowed)

          -  Patients with autoimmune diseases

          -  &quot;Redo&quot; operations

          -  Active endocarditis (ongoing antibiotic therapy)

          -  On the discretion of the operating surgeon or anaesthesiologist
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mari-Liis Kaljusto, MD, PhD</last_name>
    <phone>22118080</phone>
    <phone_ext>+47</phone_ext>
    <email>m.l.kaljusto@medisin.uio.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jarle Vaage, MD, PhD</last_name>
    <phone>22118080</phone>
    <phone_ext>+47</phone_ext>
    <email>i.j.vaage@medisin.uio.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Cardiothoracic Surgery, Oslo University Hospital, Ullevål</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mari-Liis Kaljusto, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 14, 2013</lastchanged_date>
  <firstreceived_date>March 13, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Mari-Liis Kaljusto</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Ischemic postconditioning</keyword>
  <keyword>Adult cardiac surgery</keyword>
  <keyword>Aortic valve surgery</keyword>
  <keyword>Swan-Ganz</keyword>
  <keyword>Cardiac index</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
